UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 130 filers reported holding VBI VACCINES INC in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of VBI VACCINES INC
ValueSharesWeighting
Q3 2022$80,892,000
-35.5%
114,610
-26.1%
0.00%
Q2 2022$125,406,000
-51.3%
155,1100.0%0.00%
Q1 2022$257,483,000
-29.1%
155,1100.0%0.00%
Q4 2021$362,957,000
-24.8%
155,1100.0%0.00%
Q3 2021$482,392,000
-7.2%
155,1100.0%0.00%
Q2 2021$519,619,000
+9.6%
155,110
+1.7%
0.00%
Q1 2021$474,169,000
+12.9%
152,553
-0.1%
0.00%
Q4 2020$420,071,000152,7530.00%
Other shareholders
VBI VACCINES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 52,335,002$86,876,0001.74%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$3,117,0000.25%
Newbridge Financial Services Group, Inc. 172,969$287,0000.14%
Virtus ETF Advisers LLC 69,220$115,0000.05%
ArchPoint Investors 65,000$108,0000.04%
GSA CAPITAL PARTNERS LLP 115,365$192,0000.03%
GRIMES & COMPANY, INC. 281,077$467,0000.02%
Cambridge Investment Research Advisors, Inc. 2,189,700$3,635,0000.02%
WEALTHSOURCE PARTNERS, LLC 143,500$238,0000.02%
CARDIFF PARK ADVISORS, LLC 64,100$106,0000.02%
View complete list of VBI VACCINES INC shareholders